These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1166660)

  • 1. [Platinum complexes in tumor chemotherapy].
    Belogorodskiĭ VV; Miuller NR
    Vopr Onkol; 1975; 21(8):95-105. PubMed ID: 1166660
    [No Abstract]   [Full Text] [Related]  

  • 2. [Complex compounds of platinum in the chemotherapy of malignant tumors].
    Presnov MA; Konovalova AL; Korol'chuk VP
    Vestn Akad Med Nauk SSSR; 1979; (2):68-80. PubMed ID: 105504
    [No Abstract]   [Full Text] [Related]  

  • 3. [Platinum complexes as potential antineoplastic drugs].
    Kuduk-Jaworska J
    Postepy Hig Med Dosw; 1984; 38(3):281-322. PubMed ID: 6398870
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinetic behavior versus response to chemotherapy.
    Skipper HE
    Natl Cancer Inst Monogr; 1971 Dec; 34():2-14. PubMed ID: 4946581
    [No Abstract]   [Full Text] [Related]  

  • 5. Platinum coordination complexes in cancer chemotherapy.
    Rosenberg B
    Naturwissenschaften; 1973 Sep; 60(9):399-406. PubMed ID: 4203933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-morphological comparisons of the results of the combined treatment of tumors with platinum derivatives].
    Shalimov SA; Keĭsevich LV; Nikishin LF; Trokhimenko EP; Evtushenko GV
    Vrach Delo; 1988 Jul; (7):79-82. PubMed ID: 3188478
    [No Abstract]   [Full Text] [Related]  

  • 7. Organo-platinum complexes as antitumor agents (review).
    Hill JM; Speer RJ
    Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
    Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
    Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of structure-activity relationships of platinum anticancer drugs: activation of the trans geometry.
    Farrell N
    Met Ions Biol Syst; 1996; 32():603-39. PubMed ID: 8640533
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
    Hirose A; Sato E; Fujii H; Sun B; Nishioka H; Aruoma OI
    Toxicol Appl Pharmacol; 2007 Jul; 222(2):152-8. PubMed ID: 17555784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coordinated platinum compounds in experimental and clinical oncology].
    Lobanova EA; Kozlova MD; Singin AS; Serebriakov NG
    Med Radiol (Mosk); 1984 Jun; 29(6):59-63. PubMed ID: 6376996
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination cancer therapy: Presidential address.
    Frei E
    Cancer Res; 1972 Dec; 32(12):2593-607. PubMed ID: 4118763
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronochemotherapy of neoplasms].
    Lackowska B
    Nowotwory; 1990; 40(3):168-75. PubMed ID: 2243817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on the mechanism of action of hydroxyurea.
    Yarbro JW
    Cancer Res; 1968 Jun; 28(6):1082-7. PubMed ID: 5658441
    [No Abstract]   [Full Text] [Related]  

  • 15. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
    Morimoto M; Green D; Rahman A; Goldin A; Schein PS
    Cancer Res; 1980 Aug; 40(8 Pt 1):2762-7. PubMed ID: 6771004
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antitumor activity of mixed cis-complexes of platinum(II) with ammonia and cycloalkylamines].
    Konovalova AL; Presnov MA; Chel'tsov PA; Kravchenko AN; Ivanov VB
    Dokl Akad Nauk SSSR; 1985; 281(1):200-3. PubMed ID: 4039648
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the mono-oxygenase system in realizing the biological effects of cisplatin].
    Chekhun VF; Pel'kis FP; Kulik GI
    Vopr Onkol; 1991; 37(9-10):954-8. PubMed ID: 1842656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin and radiotherapy].
    Dühmke E
    Strahlentherapie; 1985 Jun; 161(6):367-73. PubMed ID: 3892778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.